Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen and Novartis Institute in Research Deal

Premium

S

AN DIEGO, Calif.--Invitrogen and the Novartis Institute for Functional Genomics announced that they will collaborate to develop collections of full-length genes for expression and protein structural studies. The Novartis institute will gain access to Invitrogen’s advanced cloning technologies and expression systems in order to develop new reagents for research. Invitrogen said that tools developed through the collaboration will strengthen its Invirtro-genomics program that provides tools and services to genomic researchers.

Filed under

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.